Open AccessRemdesivir for COVID-19: Why Not Dose Higher?
Author(s) -
Victoria C. Yan,
Florian Müller
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02713-20
Subject(s) - clinical trial , medicine , randomized controlled trial , regimen , interim , interim analysis , intensive care medicine , law , political science